Radiopharmaceuticals - Diagnostic use
Research News and Information

Tuesday, November 24, 2009

Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation.

14 Dec 2009 BACKGROUND: In adult living-donor liver transplantation (LDLT), the assessment of the graft functional reserve is very important. We evaluated the graft functional reserve by technetium-99m-diethylenetriaminepenta-acetic acid-galactosyl-human serum ... Read more...

Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.

30 Oct 2009 BACKGROUND AND OBJECTIVES: F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) has been used for diagnosis and staging of malignant diseases. However, the prognostic significance of FDG uptake on PET had not been sufficiently evaluated in ... Read more...

[Diagnosis of fever of unknown origin (FUO). Positron emission tomography/computed tomography (PET-CT)]

4 Oct 2009 Nuclear medicine imaging is now well accepted for the localization of septic foci. But in patients the results of infection scintigraphy, radiology and ultrasound remain unsatisfactory in the diagnosis of fever of unknown origin (FUO). In contrast ... Read more...

Latest indexed articles for 'Radiopharmaceuticals - Diagnostic use'

These are the very latest articles for this heading:

• Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation. 14 Dec 2009
• Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma. 30 Oct 2009
• [Diagnosis of fever of unknown origin (FUO). Positron emission tomography/computed tomography (PET-CT)] 4 Oct 2009
• (68)Ga-DOTA-TOC/NOC in bronchial carcinoids. 29 Sep 2009
• FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome. 29 Sep 2009
• Residual brain viability, evaluated by (99m)Tc-ECD SPECT, in patients with suspected brain death and with confounding clinical factors. 29 Sep 2009
• Evaluation of myocardial viability with thallium-201 infusion MPSPECT after oral glucose application in patients with chronic coronary artery disease. 29 Sep 2009
• Clinical significance of diffusely increased splenic uptake on FDG-PET. 29 Sep 2009
• Stroke incidentally identified using improved positron emission tomography for microglial activation. 29 Sep 2009
• Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy. 29 Sep 2009
• Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. 29 Sep 2009
• Pharmacokinetics of (99m)Tc-MAG3. 29 Sep 2009
• [Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma] 14 Sep 2009
• The editor's roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction. 13 Sep 2009
• Three synchronous tumours identified by FDG-PET/CT. 5 Sep 2009
• Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Sep 2009
• Positron emission tomography in the diagnosis and management of intracranial germ cell tumours. 30 Aug 2009
• Imaging left ventricular muscarinic receptor heterogeneity: a tool to evaluate individuals at risk for sudden death? 30 Aug 2009
• In vitro evaluation of feline leukocytes radiolabeled in whole blood with 99mTc stannous colloid. 30 Aug 2009
• Scintigraphic assessment of the metacarpophalangeal and metatarsophalangeal joints of horses with joint pain. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Radiopharmaceuticals'

Definition: Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)

Registry Number: 0

Descriptor UI: D019275

Alternative terms: Radiopharmaceuticals;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.720.470.410.650;

History Note: 97

Technical Notes: pharmaceuticals as source of radiation in radiother & radioisotope scanning; D25-26 qualif